T42.1X3

Clinical Causes: Intentional ingestion or overdose in cases of assault or self-harm Accidental ingestion, especially in environments where medications are accessible to children or untrained individuals Misuse or abuse of iminostilbene-containing medications Tampering or deliberate poisoning with the intent to harm

Key Symptoms: Nausea and vomiting Dizziness or lightheadedness Weakness or fatigue Confusion or altered mental state Drowsiness or sedation Tremors or involuntary movements Seizures in severe cases Respiratory depression or difficulty breathing Cardiovascular irregularities such as low blood pressure

Diagnosis Path: Diagnosis typically involves a thorough medical history and physical examination. Laboratory tests such as blood and urine analyses are used to detect elevated levels of iminostilbenes or their metabolites. Additionally, healthcare providers may perform an electrocardiogram (ECG) to assess heart function. The patient's clinical presentation, combined with toxicology reports, helps confirm poisoning. In suspected assault cases, police reports and investigation findings may support the diagnosis.

Treatment Protocols: Treatment strategies focus on stabilizing the patient and eliminating the poison. Immediate steps may include supportive care such as monitoring vital signs, administering activated charcoal to prevent absorption, and ensuring airway patency. In severe cases, specific antidotes or medications that counteract the toxic effects may be used. Hospitalization for close observation and supportive therapy is common. Additional treatments may involve intravenous fluids, medications to manage seizures, and interventions to support cardiac and respiratory function. Psychiatric evaluation and counseling could be necessary, especially in assault-related cases, to address underlying issues or prevent future incidents.